As the year comes to a close, we would like to recognize all of the people who have contributed to the growth and continued success of Contemporary OB/GYN.
Catherine Y. Spong, MD
Since joining Contemporary OB/GYN in April as Editor-in-Chief, Catherine Y. Spong, MD has gracefully and skillfully led our team through a year no one saw coming.
Jon I. Einarsson, MD, MPH, PHD
Thank you to our Deputy Editor, Jon I. Einarsson, MD, MPH, PHD, for his continued support and valuable contributions.
Thank you to the esteemed members of our Editorial Advisory Board; We appreciate all of the work you do. We would also like to recognize the Board’s newest members who joined with enthusiasm, despite a global pandemic: Yalda Afshar, MD, PHD, Christine Isaacs, MD, and Laura Riley, MD. Welcome to the team!
Thank you to former Editorial Advisory Board member Sharon T. Phelan, MD, for her keen insights and expertise, and to Judith M. Orvos, long-time editorial consultant, whose contributions have helped shape the magazine into what it is today.
We are excited to begin another year with such a distinguished team behind us, and with you, our readers, to join the conversation as learners, practitioners and educators. We are eager to begin another wonderful year with you.
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More